世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

U.S. Wound Debridement Market Size, Share & Trends Analysis Report By Product (Gels, Ointments & Creams, Surgical Devices, Medical Gauzes), By Method, By Wound Type, By End-use, By Mode of Purchase, And Segment Forecasts, 2025 - 2033

U.S. Wound Debridement Market Size, Share & Trends Analysis Report By Product (Gels, Ointments & Creams, Surgical Devices, Medical Gauzes), By Method, By Wound Type, By End-use, By Mode of Purchase, And Segment Forecasts, 2025 - 2033


U.S. Wound Debridement Market Summary The U.S. wound debridement market size was valued at USD 1.53 billion in 2024 and is projected to reach USD 2.26 billion by 2033, growing at a CAGR of 4.3% ... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Grand View Research
グランドビューリサーチ
2025年7月8日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
電子ファイル - ご注文後3営業日前後 80 英語

 

Summary

U.S. Wound Debridement Market Summary

The U.S. wound debridement market size was valued at USD 1.53 billion in 2024 and is projected to reach USD 2.26 billion by 2033, growing at a CAGR of 4.3% from 2025 to 2033. The increasing prevalence of diabetes, obesity, and the growing number of traumatic injuries and chronic wounds continue to drive demand for advanced wound debridement solutions.

According to the CDC, approximately 129 million Americans live with at least one major chronic illness, and nearly 2% of the population suffers from chronic wounds, with incidence rising notably among older adults. These wounds, such as diabetic foot ulcers, pressure sores, and venous stasis ulcers, present significant clinical challenges and are associated with extended healing times, increased risk of complications, and substantial healthcare resource consumption.

On the regulatory and innovation front, U.S. federal agencies like the FDA are actively reshaping the landscape. The FDA has proposed reclassifying certain wound-care products-gels, creams, ointments, and liquid washes containing antimicrobials-into Class II or III devices, requiring more rigorous oversight through 510(k) notifications or premarket approvals (PMAs).

U.S. Wound Debridement Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound debridement market report based on product, method, wound type, mode of purchase, and end use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Gels
• Ointments & Creams
• Surgical Devices
• Medical Gauzes
• Ultrasonic Devices
• Others
• Method/Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Autolytic
• Enzymatic
• Surgical
• Mechanical
• Others
• Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
• Pressure Ulcers
• Diabetic Foot Ulcers
• Venous Leg Ulcers
• Burn Wound
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Homecare
• Others
• Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
• Prescription
• Over The Counter
• Others

ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Wound Debridement Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. Wound Debridement Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
Chapter 4. U.S. Wound Debridement Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Wound Debridement Market: Product Movement Analysis
4.3. U.S. Wound Debridement Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Gels
4.4.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Ointments & Creams
4.5.1. Ointments & Creams Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Surgical Devices
4.6.1. Surgical Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Medical Gauzes
4.7.1. Medical Gauzes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Ultrasonic Devices
4.8.1. Ultrasonic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Wound Debridement Market: Method/Procedures Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Wound Debridement Market: Method/Procedures Movement Analysis
5.3. U.S. Wound Debridement Market Size & Trend Analysis, by Method/Procedures, 2021 to 2033 (USD Million)
5.4. Autolytic
5.4.1. Autolytic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Enzymatic
5.5.1. Enzymatic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Surgical
5.6.1. Surgical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Mechanical
5.7.1. Mechanical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Wound Debridement Market: Wound Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Wound Debridement Market: Wound Type Movement Analysis
6.3. U.S. Wound Debridement Market Size & Trend Analysis, by Wound Type, 2021 to 2033 (USD Million)
6.4. Pressure Ulcers
6.4.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Diabetic Foot Ulcers
6.5.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Venous Leg Ulcers
6.6.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Burn Wound
6.7.1. Burn Wound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Wound Debridement Market: By End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Wound Debridement Market: By End Use Movement Analysis
7.3. U.S. Wound Debridement Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
7.3.1. Hospitals
7.3.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. Homecare
7.3.2.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. Others
7.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. U.S. Wound Debridement Market: By Mode of Purchase Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. U.S. Wound Debridement Market: By Mode of Purchase Movement Analysis
8.3. U.S. Wound Debridement Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
8.3.1. Prescription
8.3.1.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.2. Over the Counter
8.3.2.1. Over the Counter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.3. Others
8.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. Zimmer Biomet
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Smith+Nephew
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Coloplast Group
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Convatec Group PLC
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. C. R. Bard
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Lohmann & Rauscher
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の 医療機器分野 での最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/08/25 10:27

148.45 円

173.94 円

202.98 円

ページTOPに戻る